INS and Insulin resistance: In vitro stimulation of human or mouse adipocytes with the NOD1 ligand iE-DAP increased pro-inflammatory responses and weakened insulin receptor signaling, resulting in reduced insulin-stimulated glucose uptake and insulin resistance [16,17].